Projects funded by the NCN
Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell therapy: identification of novel therapeutic vulnerabilities
2021/43/O/NZ5/02693
Keywords:
ALL CAR-T relapse mutation CD19 mechanism
Descriptors:
- NZ5_7: Human disease treatment
- NZ2_2: Genomics, transcriptomics, epigenomics
- NZ2_7: Bioinformatics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 3 - announced on 2021-09-15
Amount awarded: 686 800 PLN
Project start date (Y-m-d): 2022-04-26
Project end date (Y-m-d): 2026-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.